Adherence to hydroxychloroquine in patients ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Adherence to hydroxychloroquine in patients with systemic lupus: contrasting results and weak correlation between assessment tools
Auteur(s) :
Hachulla, Eric [Auteur]
Le Gouellec, Noémie [Auteur]
Launay, David [Auteur]
Balquet, Marie-Helene [Auteur]
Maillard, Hélène [Auteur]
Azar, Raymond [Auteur]
Boldron, Amal [Auteur]
Bataille, Pierre [Auteur]
Lambert, Marc [Auteur]
Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement (RID-AGE) - U1167
Buchdahl, Anne-Laure [Auteur]
Allorge, Delphine [Auteur]
IMPact de l'Environnement Chimique sur la Santé humaine (IMPECS) - ULR 4483
Hatron, Pierre-Yves [Auteur]
Sobanski, Vincent [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Hennart, Benjamin [Auteur]
Clerson, Pierre [Auteur]
Morell-Dubois, Sandrine [Auteur]
Le Gouellec, Noémie [Auteur]
Launay, David [Auteur]
Balquet, Marie-Helene [Auteur]
Maillard, Hélène [Auteur]
Azar, Raymond [Auteur]
Boldron, Amal [Auteur]
Bataille, Pierre [Auteur]
Lambert, Marc [Auteur]
Facteurs de risque et déterminants moléculaires des maladies liées au vieillissement (RID-AGE) - U1167
Buchdahl, Anne-Laure [Auteur]
Allorge, Delphine [Auteur]
IMPact de l'Environnement Chimique sur la Santé humaine (IMPECS) - ULR 4483
Hatron, Pierre-Yves [Auteur]
Sobanski, Vincent [Auteur]
Lille Inflammation Research International Center (LIRIC) - U995
Hennart, Benjamin [Auteur]
Clerson, Pierre [Auteur]
Morell-Dubois, Sandrine [Auteur]
Titre de la revue :
Joint, bone, spine . revue du rhumatisme
Nom court de la revue :
Joint Bone Spine
Date de publication :
2020-05-10
ISSN :
1778-7254
Mot(s)-clé(s) :
Adherence
Systemic Lupus Hydroxychloroquine
Systemic Lupus Hydroxychloroquine
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
OBJECTIVE: Hydroxychloroquine (HCQ) is an anchor drug in the treatment of systemic lupus erythematosus (SLE). Adherence to HCQ is key for efficacy. Inaccurate evaluation of adherence could lead to non-justified switch to ...
Lire la suite >OBJECTIVE: Hydroxychloroquine (HCQ) is an anchor drug in the treatment of systemic lupus erythematosus (SLE). Adherence to HCQ is key for efficacy. Inaccurate evaluation of adherence could lead to non-justified switch to more expensive or less tolerated drugs. METHODS: Severe non-adherence rate to HCQ was estimated in a sample of SLE patients during a routine visit using blood HCQ concentration<200μg/L. Adherence was assessesd by the Medication Adherence Self-Report Inventory (MASRI)<80/100, 8-item Morisky Medication Adherence Scale (MMAS-8) ≤6/8, Health Care Provider (HCP) visual analog scale (VAS)<80/100. Same procedures were to be repeated during a further routine visit 6 to 12 months later. We described agreement and correlations between tools and compared severely non-adherent patients and others on their characteristics. RESULTS: The study involved 158 patients (86.1% females) aged 42.2±12.6 years treated with HCQ for 9.6±6.9 years. Blood HCQ concentration (mean±standard deviation) was 1046±662μg/L at visit 1 and 855±577μg/L at visit 2. At visit 1, the non-adherence rate varied from 3.2% (blood HCQ level<200μg/L) to 7.7% (MASRI), 12.4% (HCP-VAS) or 32.5% (MMAS-8). 37.8% of patients met at least one of the definitions of non-adherence. Patients' characteristics including SLE activity, damage and quality of life were similar between severely non-adherent patients and others. Correlations between blood HCQ-concentration and self-questionnaires were weak (r<0.25) and agreement between methods was poor. CONCLUSIONS: Blood HCQ concentration<200μg/L reveals severe non-adherence. Combining blood HCQ concentration with MASRI and MMAS-8 may help to better identify non-adherence in SLE. Agreement between methods was poor and correlations with HCQ level and SLE activity were weak.Lire moins >
Lire la suite >OBJECTIVE: Hydroxychloroquine (HCQ) is an anchor drug in the treatment of systemic lupus erythematosus (SLE). Adherence to HCQ is key for efficacy. Inaccurate evaluation of adherence could lead to non-justified switch to more expensive or less tolerated drugs. METHODS: Severe non-adherence rate to HCQ was estimated in a sample of SLE patients during a routine visit using blood HCQ concentration<200μg/L. Adherence was assessesd by the Medication Adherence Self-Report Inventory (MASRI)<80/100, 8-item Morisky Medication Adherence Scale (MMAS-8) ≤6/8, Health Care Provider (HCP) visual analog scale (VAS)<80/100. Same procedures were to be repeated during a further routine visit 6 to 12 months later. We described agreement and correlations between tools and compared severely non-adherent patients and others on their characteristics. RESULTS: The study involved 158 patients (86.1% females) aged 42.2±12.6 years treated with HCQ for 9.6±6.9 years. Blood HCQ concentration (mean±standard deviation) was 1046±662μg/L at visit 1 and 855±577μg/L at visit 2. At visit 1, the non-adherence rate varied from 3.2% (blood HCQ level<200μg/L) to 7.7% (MASRI), 12.4% (HCP-VAS) or 32.5% (MMAS-8). 37.8% of patients met at least one of the definitions of non-adherence. Patients' characteristics including SLE activity, damage and quality of life were similar between severely non-adherent patients and others. Correlations between blood HCQ-concentration and self-questionnaires were weak (r<0.25) and agreement between methods was poor. CONCLUSIONS: Blood HCQ concentration<200μg/L reveals severe non-adherence. Combining blood HCQ concentration with MASRI and MMAS-8 may help to better identify non-adherence in SLE. Agreement between methods was poor and correlations with HCQ level and SLE activity were weak.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
CHU Lille
Inserm
Institut Pasteur de Lille
Université de Lille
Inserm
Institut Pasteur de Lille
Université de Lille
Collections :
Date de dépôt :
2021-07-06T12:48:36Z
Fichiers
- Hachulla et al.pdf
- Version finale acceptée pour publication (postprint)
- Accès libre
- Accéder au document